BlackThorn Therapeutics was a clinical-stage biopharmaceutical company founded in 2015 and headquartered in South San Francisco, focused on discovering and developing targeted therapeutics for brain diseases and central nervous system (CNS) disorders such as major depressive disorder and schizophrenia, using a precision-medicine platform. - View it on GitHub